MedPath

丽珠集团丽珠制药厂

Ownership
-
Established
1989-11-26
Employees
-
Market Cap
-
Website
http://www.livzon.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

228

NMPA:228

Drug Approvals

Magnesium Sulfate,Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution

Product Name
硫酸镁钠钾口服用浓溶液
Approval Number
国药准字H20249519
Approval Date
Dec 1, 2024
NMPA

Lurasidone Hydrochloride Tablets

Product Name
盐酸鲁拉西酮片
Approval Number
国药准字H20249367
Approval Date
Nov 15, 2024
NMPA

Tedizolid Phosphate for Injection

Product Name
注射用磷酸特地唑胺
Approval Number
国药准字H20249164
Approval Date
Oct 22, 2024
NMPA

Rabeprazole Sodium Enteric-coated Tablets

Product Name
雷贝拉唑钠肠溶片
Approval Number
国药准字H20243719
Approval Date
Jul 23, 2024
NMPA

Perospirone Hydrochloride Tablets

Product Name
盐酸哌罗匹隆片
Approval Number
国药准字H20247136
Approval Date
Jul 10, 2024
NMPA

Omeprazole Sodium for Injection

Product Name
注射用奥美拉唑钠
Approval Number
国药准字H20041867
Approval Date
May 14, 2024
NMPA

Urokinase for Injection

Product Name
注射用尿激酶
Approval Number
国药准字H44020645
Approval Date
Apr 9, 2024
NMPA

Nimodipine Tablets

Product Name
尼莫地平片
Approval Number
国药准字H44020869
Approval Date
Apr 9, 2024
NMPA

Ciprofloxacin Hydrochloride Tablets

Product Name
盐酸环丙沙星片
Approval Number
国药准字H44025030
Approval Date
Apr 9, 2024
NMPA

Cefoperazone Sodium and Sulbactam Sodium for Injection

Product Name
海舒必
Approval Number
国药准字H20023306
Approval Date
Apr 9, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 23
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.